Page last updated: 2024-09-04

moxifloxacin and Neutropenia

moxifloxacin has been researched along with Neutropenia in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (47.83)29.6817
2010's12 (52.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aytekin, A; Bedir, O; Ispir, E; Kula Atik, T; Tas, D; Turhan, U; Yeniiz, E1
Przybylski, DJ; Reeves, DJ1
Knoebel, RW; Lee, P; Pettit, NN; Pisano, J1
Dixit, A; Jones, S; Karandikar, MV; Nakamura, MM1
Dugar, M; Rankin, WA; Rowe, E; Smith, MD1
Benjamin, RS; Frisbee-Hume, SE; Manzullo, EF; Patel, S; Rolston, KV1
Barker, EN; Chalker, VJ; Hamon, M; Jensen, J; Mitchell, J; Steer, JA; Stocki, T; Tasker, S1
Arenz, D; Böll, B; Bredenfeld, H; Chemnitz, J; Cornely, OA; Cremer, B; Hallek, M; Kaul, I; Klein, F; Mahne, M; Moritz, G; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wassmer, G1
Hangaishi, A; Kurokawa, M; Masamoto, Y; Nannya, Y; Shinohara, A; Yoshiki, Y1
Haeusler, GM; Slavin, MA1
Berk, E; Berk, V; Bozkurt, O; Demiraslan, H; Inanc, M; Karaca, H; Ozkan, M1
Slavin, MA; Thursky, KA1
Akan, H; Akova, M; Aoun, M; Calandra, T; de Bock, R; Drgona, L; Kern, WV; Marchetti, O; Paesmans, M; Viscoli, C1
Alteraz, H; Blau, H; Fabian, I; Horev-Azaria, L; Kariv, N; Kletter, Y; Shalit, I; Shechtman, I1
Buchheidt, D; Hofheinz, R; Hummel, M1
Elliott, MA; Patel, R; Prabhu, RM1
Dmitrieva, NV; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV1
Georgopoulos, A; Graninger, W; Grisold, AJ; Hirschl, AM; Presterl, E; Reichmann, S1
Bamias, A; Chamilos, G; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostis, E; Papadimitriou, C; Zorzou, PM1
Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H1
Bille, J; Calandra, T; Cometta, A; Kern, WV; Marchetti, O; Zinner, S1
Bachelot, T; Biron, P; Chelghoum, M; Chvetzoff, G; Devaux, Y; Dussart, S; Fuhrmann, C; Geoffrois, L; Ghesquieres, H; Lancry, L; Rodrigues, I; Sebban, C1
Chang, CM; Ko, WC; Lee, HC; Lee, IW; Lee, NY; Lin, YS; Wu, CJ1

Trials

4 trial(s) available for moxifloxacin and Neutropenia

ArticleYear
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Pilot Projects; Placebos; Prospective Studies; Quinolines; Stem Cell Transplantation; Treatment Outcome

2012
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectiou
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-20, Volume: 31, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clavulanic Acid; Double-Blind Method; Drug Combinations; Female; Fever; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Quinolines; Risk Factors; Treatment Outcome

2013
[Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Quinolines

2004
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:9

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aza Compounds; Ceftriaxone; Female; Fever; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Patient Discharge; Quinolines; Risk Factors; Time Factors

2008

Other Studies

19 other study(ies) available for moxifloxacin and Neutropenia

ArticleYear
Moxifloxacin-induced neutropenia in 26-year-old man.
    Journal of infection in developing countries, 2018, 10-31, Volume: 12, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Humans; Male; Moxifloxacin; Neutropenia

2018
Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies

2017
Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Moxifloxacin; Neutropenia; Retrospective Studies

2019
Safety and Tolerability of Moxifloxacin in Children.
    Journal of the Pediatric Infectious Diseases Society, 2018, Aug-17, Volume: 7, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bacterial Infections; Bilirubin; Blood Cell Count; Child; Child, Preschool; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Infant; Long QT Syndrome; Male; Moxifloxacin; Neutropenia; Retrospective Studies; Seizures

2018
"My foot hurts": a flare of rheumatoid arthritis?
    The Medical journal of Australia, 2009, Apr-06, Volume: 190, Issue:7

    Topics: Arthritis, Rheumatoid; Aza Compounds; Azithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionella longbeachae; Legionellosis; Male; Middle Aged; Moxifloxacin; Neutropenia; Osteomyelitis; Quinolines; Steroids

2009
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010, Volume: 18, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Aza Compounds; Feasibility Studies; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neutropenia; Pilot Projects; Quinolines

2010
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:11

    Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Female; Fever; Fluoroquinolones; Humans; Middle Aged; Molecular Sequence Data; Moxifloxacin; Mycoplasma; Mycoplasma Infections; Neutropenia; Phylogeny; Quinolines; RNA, Ribosomal, 16S; Sequence Analysis, DNA

2011
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Neutropenia; Quinolines; Retrospective Studies; Risk Factors; Treatment Outcome

2013
Fluoroquinolone prophylaxis: worth the cost?
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans; Male; Moxifloxacin; Naphthyridines; Neutropenia; Quinolines

2013
Moxifloxacin-associated neutropenia.
    Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Leukocyte Count; Moxifloxacin; Neutropenia; Pneumonia; Quinolines

2013
Outpatient therapy for fever and neutropenia is safe but implementation is the key.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-20, Volume: 31, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Female; Fever; Fluoroquinolones; Humans; Male; Moxifloxacin; Neoplasms; Neutropenia; Quinolines

2013
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8

    Topics: Animals; Anti-Infective Agents; Aza Compounds; Body Weight; Bronchopneumonia; Candidiasis; Ceftazidime; Cephalosporins; Cyclophosphamide; Cytokines; Fluoroquinolones; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Neutropenia; Protein Synthesis Inhibitors; Quinolines; Survival

2002
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine

2004
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-01, Volume: 38, Issue:7

    Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure

2004
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Biofilms; Blood; Culture Media; Endocarditis, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Penicillins; Quinolines; Streptococcal Infections; Teicoplanin; Viridans Streptococci

2005
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Cancer, 2005, Jun-15, Volume: 103, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Neoplasms; Neutropenia; Quinolines; Risk Assessment; Safety; Treatment Outcome

2005
Moxifloxacin prophylaxis in neutropenic patients.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:4

    Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines

2006
In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006, Volume: 25, Issue:8

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Neoplasms; Neutropenia; Quinolines

2006
Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:4

    Topics: Aged; Ankle; Anti-Infective Agents; Aza Compounds; Blood Cell Count; Cellulitis; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Moxifloxacin; Neutropenia; Quinolines

2008